Scale-Related Wins Are Only Part of the Story Its all too easy to get caught up in the weight loss wins that show up on the scale and overlook the ones that dont
Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial
As demand, accessibility and affordability increase, its likely the number of users will rise and its important for them to be informed
When asked about the results of the study, Amber Alhadeff , a neuroscientist from the Monell Chemical Senses Center, stated that she believes they open a door in terms of GLP-1 possibilities
After 26 weeks of follow-up, the two higher drug doses elicited a mean 12.1% weight reduction from baseline, whereas those on placebo lost 2.3% of their body weight
Currently, oral PYY analogs have entered preclinical research stages, with preliminary results showing they can effectively reduce food intake in mice and improve glucose tolerance (156, 162)
)
